| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 21:02:32 UTC |
|---|
| Update Date | 2022-09-22 18:34:22 UTC |
|---|
| HMDB ID | HMDB0028805 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Glutaminylproline |
|---|
| Description | Glutaminylproline, also known as Q-p dipeptide or GLN-pro, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Glutaminylproline has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make glutaminylproline a potential biomarker for the consumption of these foods. Based on a literature review very few articles have been published on Glutaminylproline. |
|---|
| Structure | N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O InChI=1S/C10H17N3O4/c11-6(3-4-8(12)14)9(15)13-5-1-2-7(13)10(16)17/h6-7H,1-5,11H2,(H2,12,14)(H,16,17)/t6-,7-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| GLN-Pro | HMDB | | L-Glutaminyl-L-proline | HMDB | | Glutaminyl-proline | HMDB | | Glutamine proline dipeptide | HMDB | | Glutamine-proline dipeptide | HMDB | | Q-p Dipeptide | HMDB | | QP Dipeptide | HMDB | | L-GLN-L-Pro | HMDB | | (2S)-1-[(2S)-2-Amino-4-(C-hydroxycarbonimidoyl)butanoyl]pyrrolidine-2-carboxylate | HMDB | | Glutaminylproline | HMDB |
|
|---|
| Chemical Formula | C10H17N3O4 |
|---|
| Average Molecular Weight | 243.263 |
|---|
| Monoisotopic Molecular Weight | 243.121906039 |
|---|
| IUPAC Name | (2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid |
|---|
| Traditional Name | (2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid |
|---|
| CAS Registry Number | 139370-58-4 |
|---|
| SMILES | N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O |
|---|
| InChI Identifier | InChI=1S/C10H17N3O4/c11-6(3-4-8(12)14)9(15)13-5-1-2-7(13)10(16)17/h6-7H,1-5,11H2,(H2,12,14)(H,16,17)/t6-,7-/m0/s1 |
|---|
| InChI Key | NJMYZEJORPYOTO-BQBZGAKWSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- N-acyl-alpha amino acid or derivatives
- Proline or derivatives
- N-acyl-alpha-amino acid
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- N-acylpyrrolidine
- Pyrrolidine carboxylic acid
- Pyrrolidine carboxylic acid or derivatives
- Fatty acyl
- Fatty amide
- Tertiary carboxylic acid amide
- Pyrrolidine
- Amino acid
- Primary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Carboxylic acid
- Azacycle
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Organic oxygen compound
- Primary aliphatic amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Amine
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -4.27 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.72 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.0375 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 9.24 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 373.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 474.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 229.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 72.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 161.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 51.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 262.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 257.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 881.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 555.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 45.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 686.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 177.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 214.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 747.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 610.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 366.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Glutaminylproline,1TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O | 2353.4 | Semi standard non polar | 33892256 | | Glutaminylproline,1TMS,isomer #2 | C[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O | 2388.3 | Semi standard non polar | 33892256 | | Glutaminylproline,1TMS,isomer #3 | C[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O | 2368.8 | Semi standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2386.1 | Semi standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2308.6 | Standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2378.5 | Semi standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2379.3 | Standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #3 | C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2423.5 | Semi standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #3 | C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2430.9 | Standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #4 | C[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C | 2471.7 | Semi standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #4 | C[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C | 2374.2 | Standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #5 | C[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C | 2441.6 | Semi standard non polar | 33892256 | | Glutaminylproline,2TMS,isomer #5 | C[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C | 2420.0 | Standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #1 | C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2428.0 | Semi standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #1 | C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2474.9 | Standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C)[Si](C)(C)C | 2513.6 | Semi standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C)[Si](C)(C)C | 2428.0 | Standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2446.9 | Semi standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2470.2 | Standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #4 | C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2491.6 | Semi standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #4 | C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2513.9 | Standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #5 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2540.0 | Semi standard non polar | 33892256 | | Glutaminylproline,3TMS,isomer #5 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2531.6 | Standard non polar | 33892256 | | Glutaminylproline,4TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2511.0 | Semi standard non polar | 33892256 | | Glutaminylproline,4TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2549.2 | Standard non polar | 33892256 | | Glutaminylproline,4TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2572.4 | Semi standard non polar | 33892256 | | Glutaminylproline,4TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2558.6 | Standard non polar | 33892256 | | Glutaminylproline,4TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2655.7 | Semi standard non polar | 33892256 | | Glutaminylproline,4TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2622.6 | Standard non polar | 33892256 | | Glutaminylproline,5TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2694.6 | Semi standard non polar | 33892256 | | Glutaminylproline,5TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2642.3 | Standard non polar | 33892256 | | Glutaminylproline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O | 2602.3 | Semi standard non polar | 33892256 | | Glutaminylproline,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O | 2639.5 | Semi standard non polar | 33892256 | | Glutaminylproline,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O | 2637.6 | Semi standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2857.9 | Semi standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2713.8 | Standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2841.2 | Semi standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2766.7 | Standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2917.9 | Semi standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 2792.8 | Standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C | 2925.1 | Semi standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C | 2797.9 | Standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C | 2915.1 | Semi standard non polar | 33892256 | | Glutaminylproline,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C | 2839.2 | Standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3114.1 | Semi standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2991.0 | Standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3157.3 | Semi standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2992.0 | Standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3107.4 | Semi standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3040.3 | Standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3186.4 | Semi standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O | 3074.6 | Standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3219.8 | Semi standard non polar | 33892256 | | Glutaminylproline,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3065.1 | Standard non polar | 33892256 | | Glutaminylproline,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3390.9 | Semi standard non polar | 33892256 | | Glutaminylproline,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 3233.6 | Standard non polar | 33892256 | | Glutaminylproline,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3446.7 | Semi standard non polar | 33892256 | | Glutaminylproline,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3222.3 | Standard non polar | 33892256 | | Glutaminylproline,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3521.9 | Semi standard non polar | 33892256 | | Glutaminylproline,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3331.5 | Standard non polar | 33892256 | | Glutaminylproline,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3727.0 | Semi standard non polar | 33892256 | | Glutaminylproline,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3449.3 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Glutaminylproline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 10V, Positive-QTOF | splash10-004i-0390000000-352cc3006c7cf857d039 | 2018-11-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 20V, Positive-QTOF | splash10-003r-7980000000-3b7a1266324df9103b4e | 2018-11-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 40V, Positive-QTOF | splash10-0q30-9100000000-187c618d99ad73d4737a | 2018-11-27 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 10V, Positive-QTOF | splash10-002f-0190000000-25dafb19ee955d7d1a94 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 20V, Positive-QTOF | splash10-001i-9730000000-fb9c6e43453b13889ec2 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 40V, Positive-QTOF | splash10-05a9-9000000000-bf90fa924f6062b559fe | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 10V, Negative-QTOF | splash10-0006-0190000000-856ae8ca7e40d0e64f0e | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 20V, Negative-QTOF | splash10-03di-4910000000-3c553fb2974702dc02c0 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glutaminylproline 40V, Negative-QTOF | splash10-03dj-9500000000-f30736a1fcefac930848 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
|
|---|
| Disease References | | Crohn's disease |
|---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
| | Iron deficiency |
|---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
|
|
|---|
| General References | - Sucov HM, Benson S, Robinson JJ, Britten RJ, Wilt F, Davidson EH: A lineage-specific gene encoding a major matrix protein of the sea urchin embryo spicule. II. Structure of the gene and derived sequence of the protein. Dev Biol. 1987 Apr;120(2):507-19. [PubMed:3030858 ]
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
|
|---|